trending Market Intelligence /marketintelligence/en/news-insights/trending/dmce603wsaczvtmqajh6cg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Biolase to implement 1-for-5 reverse stock split to regain Nasdaq compliance

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Biolase to implement 1-for-5 reverse stock split to regain Nasdaq compliance

Biolase Inc. said its board approved a 1-for-5 reverse stock split to raise its per-share price and regain compliance with Nasdaq listing requirements.

The reverse split will reduce Biolase's outstanding shares to 20,470,047 shares from 102,380,238 shares. The number of Biolase authorized shares of will be reduced to 40 million shares from 200 million.

The stock split will take effect 11:59 p.m. ET on May 10 and the company's stock will start trading on a split-adjusted basis on May 11.

The Irvine, Calif.-based medical equipment maker received a noncompliance notice in August 2017 for failing to meet Nasdaq's $1 minimum bid price requirement for 30 consecutive business days. The company said in February that it secured a 180-day extension to regain compliance.